Groups

Study

(n = 63)

Control (n = 30)

(4)

Affected area

≤1%

(n = 23)

(1)

1% - 2%

(n = 27)

(2)

≥3%

(n = 12)

(3)

CD16 + 56 (10⁶ cells/l)

241 ± 128

297 ± 258

177 ± 140

458 ± 329

p

p_1-2 > 0.05, p_2-3 > 0.05, p_1-3 > 0.05

p_1-4 < 0.05; p_2-4 > 0.05; p_3-4 < 0.05